FOSFOMYCIN TROMETHAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Fosfomycin Tromethamine patents expire, and when can generic versions of Fosfomycin Tromethamine launch?
Fosfomycin Tromethamine is a drug marketed by Alkem Labs Ltd, Amneal, Cipla, and Xiromed. and is included in four NDAs.
The generic ingredient in FOSFOMYCIN TROMETHAMINE is fosfomycin tromethamine. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fosfomycin tromethamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fosfomycin Tromethamine
A generic version of FOSFOMYCIN TROMETHAMINE was approved as fosfomycin tromethamine by XIROMED on October 6th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FOSFOMYCIN TROMETHAMINE?
- What are the global sales for FOSFOMYCIN TROMETHAMINE?
- What is Average Wholesale Price for FOSFOMYCIN TROMETHAMINE?
Summary for FOSFOMYCIN TROMETHAMINE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 39 |
| Clinical Trials: | 5 |
| Patent Applications: | 546 |
| Drug Prices: | Drug price information for FOSFOMYCIN TROMETHAMINE |
| What excipients (inactive ingredients) are in FOSFOMYCIN TROMETHAMINE? | FOSFOMYCIN TROMETHAMINE excipients list |
| DailyMed Link: | FOSFOMYCIN TROMETHAMINE at DailyMed |
Recent Clinical Trials for FOSFOMYCIN TROMETHAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Benova (Tianjin) Innovative medicine Research Co., Ltd. | Phase 3 |
| ZonMw: The Netherlands Organisation for Health Research and Development | Phase 3 |
| Saltro | Phase 3 |
Medical Subject Heading (MeSH) Categories for FOSFOMYCIN TROMETHAMINE
Anatomical Therapeutic Chemical (ATC) Classes for FOSFOMYCIN TROMETHAMINE
US Patents and Regulatory Information for FOSFOMYCIN TROMETHAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | FOSFOMYCIN TROMETHAMINE | fosfomycin tromethamine | FOR SOLUTION;ORAL | 214554-001 | Oct 21, 2021 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Xiromed | FOSFOMYCIN TROMETHAMINE | fosfomycin tromethamine | FOR SOLUTION;ORAL | 212548-001 | Oct 6, 2020 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Amneal | FOSFOMYCIN TROMETHAMINE | fosfomycin tromethamine | FOR SOLUTION;ORAL | 216600-001 | Mar 25, 2024 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cipla | FOSFOMYCIN TROMETHAMINE | fosfomycin tromethamine | FOR SOLUTION;ORAL | 211881-001 | Jan 26, 2022 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
